期刊文献+

康复新液与浓替硝唑对低危妊娠滋养细胞肿瘤MTX化疗后口腔溃疡的疗效观察 被引量:16

Clinical efficacy of Kangfuxin solution and tinidazole in the treatment of oral ulcer induced by MTX chemotherapy of patients with gestational trophoblastic neoplasia
下载PDF
导出
摘要 目的比较康复新液与浓替硝唑含漱液对低危妊娠滋养细胞肿瘤MTX化疗性口腔溃疡的临床疗效。方法我院2013年12月至2015年12月收治的低危滋养细胞肿瘤患者,选取50例合并口腔溃疡患者作为研究对象,分为2组,每组25例。治疗组:给予康复新溶液,对照组给予浓替硝唑含漱液,评价两组疗效和毒副反应。结果康复新液组治疗有效率为96%,浓替硝唑组为80%,两组比较差异有统计学意义(P<0.05)。口腔溃疡的愈合情况比较:治疗组愈合时间为(4.3±1.9)d;对照组为(7.1±2.6)d,两组比较差异有统计学意义(P<0.05)。所有患者均未发生与康复新液和浓替硝唑相关的不良反应。结论康复新液治疗低危妊娠滋养细胞肿瘤患者相关化疗性口腔溃疡安全有效,值得临床推广。 Objective To compare the effect of Kangfuxin solution and tinidazole on oral ulcer induced by MTX chemotherapy of patients with gestational trophoblastic neoplasia(GTN).Methods Fifty patients with GTN complicated with oral ulcer were randomly divided into Kangfuxin solution group(n= 25) and tinidazole group(n=25).The curative efficacy of the two groups was compared.Results The total effective rate in Kangfuxin solution group was higher than that of tinidazole group(96%vs.80%),there being significant difference between the two groups(P〈 0.05).The average healing time in Kangfuxin solution group was shorter than that of tinidazole group:(4.3 ± 1.9) d vs.(7.1 ± 2.6) d,there being significant difference between the two groups(P〈0.05).No obvious adverse reaction occurred in the two groups.Conclusion The efficacy of Kangfuxin solution in the treatment of oral ulcer induced by MTX chemotherapy is better than tinidazole,it is worthy of wide application.
作者 刘晓梅 高嵩
出处 《实用药物与临床》 CAS 2016年第6期688-691,共4页 Practical Pharmacy and Clinical Remedies
关键词 低危妊娠滋养细胞肿瘤 甲氨蝶呤 康复新液 口腔溃疡 Gestational trophoblastic neoplasia MTX Kangfuxin solution Oral ulcer
  • 相关文献

参考文献15

  • 1May T, Goldstein DP, Berkowitz RS. Current chemotherapeutic management of patients with gestational trophoblastic neoplasia [ J]. Chemother Res Prac ,2011:206-256. 被引量:1
  • 2Ngan HY,Bender H,Benedet JL,et al. Gestational trophoblast- ic neoplasia, FIGO 2000 taging and classification [ J ]. Int J Gynaecol Obstet,2003,83 : 175-177. 被引量:1
  • 3Alazzam M,Tidy J,Hancock BW, et al. First line chemothera- py in low risk gestational trophoblastic neoplasia[ J]. Cochrane Database Syst Rev ,2009 .CD007102. 被引量:1
  • 4Osborne ILl, Filiaci V, Schink JC, et al. Phase III trial of week- ly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia:a Gynecologic Oncology Group study [ J]. J Clin Onco1,2011,29 :825-831. 被引量:1
  • 5A1-Moheeriek A, AIDosari AM. Prevalence of oral lesions a- mong Saudi dental patients[ J]. Ann Saudi Med,2009,29(5 ) : 365 -368. 被引量:1
  • 6. Sonis ST, Elting LS, Keefe D, et al. Mucositis Study Section of the Multinational Association for Supportive Care in Cancer Perspectives on cancer therapy-induced mucosal injurd:patho- genesis, easurement, epidemiology, and consequences for pa- tients[ J]. Cancer,2004,100 : 1995-2025. 被引量:1
  • 7Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemo- therapy: part 1, pathogenesis and prophylaxis of mucositis [ J ]. Head Neck,2003,25:1057-1070. 被引量:1
  • 8Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease[ J]. Lancet,2010,376:717-729. 被引量:1
  • 9Kramer IR, Pindborg JJ,Bezroukov V, et al. World Health Or- ganization. Guide to epidemiology and diagnosis of oral muco- sal diseases and conditions [ J ]. Community Dent Oral Epide- miol, 1980,8 : 1-26. 被引量:1
  • 10Dhanda S. Ramani S, Thakur M. Gestational trophoblastic dis- ease:a multimodality imaging approach with impact on diag- nosis and management [ J]. Radiol Res Prac, 2014, 2014: 842751. 被引量:1

同被引文献186

引证文献16

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部